Le Lézard
Classified in: Health
Subject: PER

Celiac Disease Foundation Announces Appointment of Casey Guber to its Board of Directors


LOS ANGELES, Jan. 27, 2022 /PRNewswire/ -- The Celiac Disease Foundation, the nation's leading patient advocacy organization for celiac disease, announces its newest appointee, Casey Guber, to its Board of Directors. The officers for 2022 are Chair Adrienne Bender, Vice Chair John Wagner, Secretary Brad Herrema, and Treasurer Jordan Ramer. Reappointed are Directors Lee Jones, Jamie Resin, Linda Solomon, John Wagner, and Kristin Yarema.

Casey's passion for joining the Celiac Disease Foundation is personal. His daughter, Charlie, was just over 2-years-old when she lost 20% of her body weight and was diagnosed with failure to thrive. She became disengaged and experienced personality changes. Charlie had such low energy there were times she fell asleep on the playground at preschool. Casey's wife, Erika, is a physician and began working with their pediatrician to help Charlie. Ultimately, blood tests diagnosed Charlie with celiac disease.

With this news, Casey and Ericka decided to make substantial lifestyle changes, which included creating a completely gluten-free household to support Charlie, who is now 3 ½ and thriving. 

"I realize how impactful this diagnosis is. It affects the way a family shops, eats, socializes, and experiences the world," stated Casey. "A simple weekend trip can suddenly get complicated trying to find the right food and restaurants. I want to help people better navigate this disease and hopefully move towards a cure."  

Casey is currently the Chief Executive Officer at Rose Medical Center in Denver, Colorado. He earned his Bachelor of Science in Business Administration from the University of Colorado Boulder, and his Master of Science in Health Administration from the University of Colorado Denver. Casey lives in Denver with his wife, Erika, Charlie, and her little brother, Landon. 

To view biographies of Celiac Disease Foundation directors, click here.

About the Celiac Disease Foundation
The Celiac Disease Foundation is the nation's leading patient advocacy organization for celiac disease. Since its founding in 1990, the Celiac Disease Foundation continues to champion many battles: federal funding for celiac disease research and labeling standards for gluten-free foods, widespread patient and provider education, access to mainstream gluten-free products, improved diagnostic tools, and accelerated development of therapeutic treatments and a cure. For more information, visit celiac.org.

Media Contact: [email protected]

SOURCE Celiac Disease Foundation


These press releases may also interest you

at 22:20
The Sasakawa Peace Foundation (SPF), Citizen's Network for Global Activities (CINGA), and Forum for Refugees Japan (FRJ), are pleased to announce the opening of the Support Center for Refugees Japan (Support-R) in Tokyo on May 19, 2022. Russia's...

at 22:10
Global superstar and immersive entrepreneur, J Balvin, has announced the creation of OYE, the new bilingual, interactive wellness app. Balvin, the company's co-founder and Chief Dream Officer, co-founded OYE with happiness activist and ed-tech...

at 22:05
AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced it is adding viral vector suspension technology and capacity for the development and manufacturing of gene therapies at its...

at 20:25
Cari M. Schwartz has been and is, currently, involved with many non-profit organizations that focus on healthcare needs of people across the country. As a Partner Attorney at Kantor & Kantor, LLP, it is her passion to bring education about patient's...

at 19:05
Imugene Limited , a clinical stage immuno-oncology company, and City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced that the first patient was dosed in a Phase 1 clinical trial evaluating...

at 19:00
Carebook Technologies Inc. ("Carebook" or the "Company") (XFRA: PMM1), a leading Canadian provider of innovative digital health solutions, is pleased to announce the completion of its rights offering (the "Rights Offering"), which expired at 5:00...



News published on 27 january 2022 at 04:00 and distributed by: